|
Adverse Effects
Citations 421-430 of 590 total displayed.
|
Past content
(since Mar 1998):
|
- Controversies
Authors’ Reply to Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
- Bruce M. Psaty; Curt D. Furberg; Wayne A. Ray; Noel S. Weiss
JAMA 2004; 292: 2658-2659.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Antidepressant Risks for Adults
- Tracy Hampton
JAMA 2004; 292: 2457-b.
[Extract]
[Full text]
[PDF]
- Original Contributions
Guillain-Barré Syndrome Following Influenza Vaccination
- Penina Haber; Frank DeStefano; Fredrick J. Angulo; John Iskander; Sean V. Shadomy; Eric Weintraub; Robert T. Chen
JAMA 2004; 292: 2478-2481.
[Abstract]
[Full text]
[PDF]
- The World in Medicine
Caution on Head Injury Rx
- Joan Stephenson
JAMA 2004; 292: 2329.
[Extract]
[Full text]
[PDF]
- Letters
MMR Vaccination and Febrile Seizures—Reply
- Mogens Vestergaard; Kreesten Meldgaard Madsen; Jørn Olsen; Anders Hviid; Jan Wohlfahrt; Mads Melbye; Poul Thorsen; Diana Schendel
JAMA 2004; 292: 2083-a-2084-a.
[Extract]
[Full text]
[PDF]
- Letters
MMR Vaccination and Febrile Seizures
- Eelko Hak; Marc J. M. Bonten
JAMA 2004; 292: 2083.
[Extract]
[Full text]
[PDF]
- Reviews
Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
- Thomas G. Roberts Jr; Bernardo H. Goulart; Lee Squitieri; Sarah C. Stallings; Elkan F. Halpern; Bruce A. Chabner; G. Scott Gazelle; Stan N. Finkelstein; Jeffrey W. Clark
JAMA 2004; 292: 2130-2140.
[Abstract]
[Full text]
[PDF]
- Editorials
Risks and Benefits of Phase 1 Clinical Trials Evaluating New Anticancer Agents: A Case for More Innovation
- Eric X. Chen; Ian F. Tannock
JAMA 2004; 292: 2150-2151.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Antidepressant Warnings
- Tracy Hampton
JAMA 2004; 292: 1946-c.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Pregnancy and Medication
- Tracy Hampton
JAMA 2004; 292: 1946-a.
[Extract]
[Full text]
[PDF]
|
|
